Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q3
добавлен 04.11.2024
Adverum Biotechnologies Мультипликаторы 2011-2024 | ADVM
Мультипликаторы по годам Adverum Biotechnologies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.5 | -0.5 | -1.2 | -6.7 | -10.3 | -2.6 | -6.2 | -0.9 | -3.3 | -35.5 | - | - | - |
P/S |
49.6 | - | 23.0 | - | 2664.1 | 115.4 | 187.7 | 71.0 | 66.9 | 1578.5 | - | - | - |
EPS |
-1.2 | -1.6 | -1.5 | -1.4 | -1.0 | -1.2 | -1.3 | -3.1 | -1.9 | -2.5 | -1.4 | -0.5 | - |
EV (Enterprise Value) |
193 млн | 136 млн | 262 млн | 776 млн | 648 млн | 43.3 млн | 294 млн | -99.9 млн | -54.5 млн | 756 млн | 739 тыс. | 1.03 млн | - |
EBITDA per Share |
-1.17 | -1.52 | -1.44 | -1.78 | -1.04 | -1.16 | -1.3 | -1.46 | -1.72 | -1.07 | - | - | - |
EV/EBITDA |
-1.3 | -6.4 | -9.0 | -0.4 | -4.9 | 2.2 | 1.5 | -30.7 | - | - | - | ||
PEG |
-0.32 | -0.07 | -0.31 | 0.08 | -0.72 | -0.3 | -0.1 | 0.01 | 0.07 | 0.09 | - | - | - |
P/B |
2.1 | 0.4 | 0.5 | 1.8 | 3.8 | 0.9 | 1.9 | 0.5 | 0.6 | 6.0 | - | - | - |
P/CF |
-2.0 | -0.7 | -1.6 | -8.7 | -9.7 | -3.4 | -7.5 | -2.5 | -4.0 | -137.0 | - | - | - |
ROE % |
-140.37 | -85.14 | -46.03 | -27.05 | -36.86 | -36.10 | -30.51 | -52.76 | -18.79 | -16.99 | - | - | - |
ROA % |
-67.72 | -50.11 | -33.10 | -24.35 | -28.95 | -34.02 | -27.81 | -48.49 | -17.95 | -15.69 | - | - | - |
ROCE % |
-148.55 | -86.57 | -46.21 | -25.55 | -33.71 | -36.04 | -30.77 | -24.29 | -17.56 | -15.60 | - | - | - |
Current Ratio |
1.9 | 2.4 | 3.6 | 20.8 | 9.1 | 19.5 | 18.2 | 22.8 | 39.7 | 29.3 | - | - | - |
DSO |
- | - | - | - | - | - | - | 222.3 | 70.7 | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Adverum Biotechnologies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.3 | -0.89 | -1.5 | -3.26 | -3.13 | -2.9 | - | -0.4 | -0.44 | -0.38 | - | -0.39 | -0.45 | -0.29 | - | -0.31 | -0.36 | -0.31 | - | -0.25 | -0.23 | -0.23 | -0.25 | -0.34 | -0.3 | -0.3 | -0.32 | -0.32 | -0.27 | -0.38 | -0.54 | -0.35 | -1.76 | -0.57 | -0.55 | -0.55 | -0.38 | -0.38 | -0.46 | -0.5 | -2.27 | -0.45 | -1.01 | -0.22 | -0.2 | -0.01 | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -1.57 | - | - | -2.86 | - | -0.36 | -0.41 | -0.37 | - | -0.36 | -0.43 | -0.28 | - | -0.3 | -0.35 | -0.31 | - | -0.26 | -0.25 | -0.24 | - | -0.37 | -0.31 | -0.3 | - | -0.32 | -0.27 | -0.38 | - | -0.34 | -1.76 | -0.56 | - | -0.54 | -0.38 | -0.38 | - | -0.48 | -1.21 | -0.43 | - | -0.21 | -0.19 | - | - | - | - | - | - | - | - | - |
ROE % |
-75.44 | -80.63 | -88.06 | -93.72 | -80.97 | -74.87 | -50.59 | -61.67 | -53.50 | -47.26 | -29.64 | -36.03 | -31.33 | -26.36 | -18.39 | -27.60 | -30.42 | -32.25 | -26.04 | -33.83 | -35.03 | -35.83 | -36.10 | -36.36 | -33.45 | -30.31 | -30.51 | -32.86 | -31.98 | -54.37 | -52.76 | -47.95 | -46.89 | -22.16 | -18.79 | -20.16 | -20.11 | -19.65 | -16.99 | 34.94 | 50.36 | 62.55 | 63.67 | 18.68 | 8.78 | - | - | - | - | - | - | - | - | - |
ROA % |
-44.82 | -46.30 | -49.56 | -52.38 | -47.74 | -46.36 | -33.05 | -40.87 | -36.62 | -33.37 | -22.41 | -28.16 | -26.10 | -23.72 | -16.55 | -23.79 | -25.27 | -25.93 | -20.46 | -27.79 | -30.37 | -32.47 | -34.02 | -34.01 | -31.04 | -27.89 | -27.81 | -30.03 | -29.28 | -49.90 | -48.49 | -44.27 | -43.51 | -20.92 | -17.95 | -19.04 | -18.81 | -18.26 | -15.69 | -349.64 | -419.47 | -482.78 | -481.75 | -141.38 | -66.45 | - | - | - | - | - | - | - | - | - |
ROCE % |
-81.04 | -85.98 | -92.72 | -97.69 | -83.77 | -76.60 | -51.21 | -62.34 | -53.78 | -47.49 | -29.79 | -36.23 | -31.55 | -26.65 | -18.78 | -28.54 | -31.86 | -34.21 | -27.95 | -39.61 | -41.52 | -42.21 | -30.48 | -38.40 | -34.65 | -31.33 | -23.50 | -30.23 | -29.04 | -51.17 | -42.62 | -48.25 | -47.14 | -22.35 | -13.32 | -18.63 | -18.32 | -17.39 | -9.36 | 0.11 | 14.90 | 26.47 | 18.06 | 18.06 | 8.59 | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.6 | 3.0 | 3.1 | 2.1 | 2.2 | 2.3 | 2.4 | 2.7 | 2.9 | 3.3 | 3.6 | 3.4 | 3.6 | 9.9 | 10.0 | 10.0 | 10.0 | 10.0 | 4.7 | 4.7 | 4.7 | 4.7 | 17.3 | 17.3 | 17.3 | 17.3 | 11.3 | 11.3 | 11.3 | 11.3 | 12.4 | 12.4 | 12.4 | 12.4 | 22.5 | 22.5 | 22.5 | 22.5 | 13.0 | 13.0 | 13.0 | 13.0 | 0.8 | 0.8 | 0.8 | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87.5 | 165.7 | 204.7 | 263.4 | 229.8 | 42.7 | 43.0 | 201.8 | 100.9 | 1.8 | 3.6 | 2.7 | 12.2 | - | 24.3 | 2.4 | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87.5 | 165.7 | 204.7 | 263.4 | 229.8 | 42.7 | 43.0 | 201.8 | 100.9 | 1.8 | 3.6 | 2.7 | 12.2 | - | 24.3 | 2.4 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 87.5 | 165.7 | 204.7 | 263.4 | 229.8 | 42.7 | 43.0 | 201.8 | 100.9 | 1.8 | 3.6 | 2.7 | 12.2 | - | 24.3 | 2.4 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD